The latest closing stock price for Cartesian Therapeutics as of July 17, 2025 is 12.53.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-970 today, roughly -1 times their original investment - a -32.31% compound annual growth rate over 9 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 26.50, which is 111.5% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 8.46, which is 32.5% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 15.84.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-970 today, roughly -1 times their original investment - a -32.31% compound annual growth rate over 9 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 26.50, which is 111.5% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 8.46, which is 32.5% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 15.84.